Mesothelin expression remodeled the immune-matrix tumor microenvironment predicting the risk of death in patients with malignant pleural mesothelioma

BACKGROUND: The combination of immunobiological agents with immune checkpoint proteins is a promising treatment for malignant pleural mesothelioma (MPM). Mesothelin and anti-PD-L1 antibody-drug conjugates specifically target malignant neoplastic cells, inhibit the migration and invasion of neoplasti...

Descripción completa

Detalles Bibliográficos
Autores principales: Qualiotto, Aline Nery, Baldavira, Camila Machado, Balancin, Marcelo, Ab’Saber, Alexandre, Takagaki, Teresa, Capelozzi, Vera Luiza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601658/
https://www.ncbi.nlm.nih.gov/pubmed/37901248
http://dx.doi.org/10.3389/fimmu.2023.1268927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601658/
https://www.ncbi.nlm.nih.gov/pubmed/37901248
http://dx.doi.org/10.3389/fimmu.2023.1268927

Ejemplares similares